693 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Friday’s Close
LLY Eli Lilly and Company $105.71 $113.53B N/A
Article Searches
AstraZeneca's Bydureon Fails to Reduce Cardiovascular Risk http://www.zacks.com/stock/news/261771/astrazenecas-bydureon-fails-to-reduce-cardiovascular-risk?cid=CS-ZC-FT-261771 May 24, 2017 - AstraZeneca plc (AZN) announced top-line results from the EXSCEL study evaluating the cardiovascular (CV) safety profile of its type II diabetes drug Bydureon.
Merck's (MRK) Keytruda Gets FDA Nod for Solid Tumor Cancers http://www.zacks.com/stock/news/261767/mercks-mrk-keytruda-gets-fda-nod-for-solid-tumor-cancers?cid=CS-ZC-FT-261767 May 24, 2017 - Merck & Co., Inc. (MRK) announced that Keytruda, has received accelerated approval for the treatment of microsatellite instability-high (MSI-H) or mismatch repair deficient solid tumors .
Here's Why Radius Health Gained as Much as 20.2% Today https://www.fool.com/investing/2017/05/22/heres-why-radius-health-gained-as-much-as-202-toda.aspx?source=iedfolrf0000001 May 22, 2017 - A leading competitor's osteoporosis drug encountered serious side effects in a late stage trial.
Novartis' (NVS) Lung Cancer Drug Gets Positive CHMP Opinion http://www.zacks.com/stock/news/261465/novartis-nvs-lung-cancer-drug-gets-positive-chmp-opinion?cid=CS-ZC-FT-261465 May 22, 2017 - Novartis (NVS) recently announced that the CHMP of the European Medicines Agency (EMA) has recommended the approval of a label expansion of Zykadia.
Sanofi Wins Favorable CHMP Opinion for Biosimilar Humalog http://www.zacks.com/stock/news/261459/sanofi-wins-favorable-chmp-opinion-for-biosimilar-humalog?cid=CS-ZC-FT-261459 May 22, 2017 - Sanofi (SNY) recently announced that the CHMP has given a positive opinion, recommending marketing approval to a biosimilar version of Humalog (insulin lispro).
3 Top Animal-Health Companies to Buy in 2017 https://www.fool.com/investing/2017/05/21/3-top-animal-health-companies-to-buy-in-2017.aspx?source=iedfolrf0000001 May 21, 2017 - Looking for top animal-health companies to buy? Check out Zoetis, Merck, and Lilly.
5 Reasons Why Merck (MRK) is a Good Stock to Buy Now http://www.zacks.com/stock/news/260894/5-reasons-why-merck-mrk-is-a-good-stock-to-buy-now?cid=CS-ZC-FT-260894 May 17, 2017 - It looks like a great stock to buy now.
Teva (TEVA) Launches Glumetza Generic, Inks Deal with Otsuka http://www.zacks.com/stock/news/260741/teva-teva-launches-glumetza-generic-inks-deal-with-otsuka?cid=CS-ZC-FT-260741 May 16, 2017 - Teva Pharmaceutical Industries Ltd. (TEVA) announced the launch of a generic version of Valeant Pharmaceuticals International, Inc.'s (VRX) diabetes drug, Glumetza, in the U.S.
Lilly's Migraine Drug Phase III Trials Meet Primary Endpoint http://www.zacks.com/stock/news/260624/lillys-migraine-drug-phase-iii-trials-meet-primary-endpoint?cid=CS-ZC-FT-260624 May 15, 2017 - Eli Lilly and Company (LLY) recently announced that its migraine candidate, galcanezumab, met primary endpoint in phase III studies
The Zacks Analyst Blog Highlights: United Technologies, Lilly, American Express, Aetna, Las Vegas Sands and Capital One http://www.zacks.com/stock/news/259855/the-zacks-analyst-blog-highlights-united-technologies-lilly-american-express-aetna-las-vegas-sands-and-capital-one?cid=CS-ZC-FT-259855 May 09, 2017 - The Zacks Analyst Blog Highlights: United Technologies, Lilly, American Express, Aetna, Las Vegas Sands and Capital One

Pages: 1...5556575859606162636465...70

<<<Page 60>